| scholarly article | Q13442814 |
| P50 | author | Ajla Kulaglic | Q91579213 |
| Belma Ramic-Brkic | Q91579215 | ||
| Mirsada Causevic | Q91579220 | ||
| P2093 | author name string | Edin Begic | |
| Zijo Begic | |||
| Suncica Hadzidedic | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| The diagnosis and management of mild cognitive impairment: a clinical review | Q27693353 | ||
| Aptamer-based multiplexed proteomic technology for biomarker discovery | Q28744329 | ||
| Multiple imputation: dealing with missing data | Q30638883 | ||
| Cognitive impairment and cardiovascular disease: so near, so far. | Q30826479 | ||
| B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia | Q33441223 | ||
| Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. | Q33526944 | ||
| Cardiovascular risk factors and dementia | Q34013162 | ||
| Use of medical services and medicines attributable to diabetes in Sub-Saharan Africa | Q34172425 | ||
| Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study | Q35034827 | ||
| Brain natriuretic peptide is a potent vasodilator in aged human microcirculation and shows a blunted response in heart failure patients | Q35153293 | ||
| Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults | Q35214759 | ||
| Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study | Q35434368 | ||
| The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. | Q35581313 | ||
| Natriuretic peptide metabolism, clearance and degradation | Q35831469 | ||
| Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease | Q36183810 | ||
| BNP as a biomarker in heart disease | Q36342538 | ||
| Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis. | Q36354245 | ||
| Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. | Q50646784 | ||
| Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. | Q51758135 | ||
| A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. | Q51760901 | ||
| Cardiac dysfunction and cognition in older adults with heart failure. | Q51889848 | ||
| Biomarkers for heart failure: small molecules with high clinical relevance. | Q52570841 | ||
| Outlier Removal in Model-Based Missing Value Imputation for Medical Datasets. | Q54961197 | ||
| 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure | Q57629468 | ||
| Associations between birth characteristics and age-related cognitive impairment and dementia: A registry-based cohort study | Q61851183 | ||
| The role of BNP testing in heart failure. | Q36683074 | ||
| Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease | Q36764094 | ||
| Age, APOE and sex: Triad of risk of Alzheimer's disease | Q36998533 | ||
| Heart failure and cognitive impairment: challenges and opportunities. | Q37017400 | ||
| Utility of brain natriuritic peptide as a diagnostic tool for congestive heart failure in the elderly | Q37109922 | ||
| Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments | Q37135114 | ||
| Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease | Q37356606 | ||
| Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study | Q38152257 | ||
| Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence | Q38222635 | ||
| Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis | Q38238315 | ||
| Heart failure and risk of dementia: a Danish nationwide population-based cohort study | Q38405743 | ||
| Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies | Q38483442 | ||
| Statistical data preparation: management of missing values and outliers | Q38631420 | ||
| A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood | Q38653401 | ||
| Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease. | Q38675620 | ||
| Association of Plasma DPP4 Activity With Mild Cognitive Impairment in Elderly Patients With Type 2 Diabetes: Results From the GDMD Study in China | Q40670555 | ||
| The use of N-terminal pro-brain natriuretic Peptide to evaluate vascular disease in elderly patients with mental illness | Q42081622 | ||
| Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure | Q43573505 | ||
| Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care | Q43602128 | ||
| B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure | Q44038471 | ||
| Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). | Q44205751 | ||
| Association between cardiovascular disease and dementia. | Q47105913 | ||
| Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers | Q47605927 | ||
| Frequent mild cognitive deficits in several functional domains in elderly patients with heart failure without known cognitive disorders | Q48084714 | ||
| Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure | Q48586817 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mild cognitive impairment | Q1472703 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | e0212261 | |
| P577 | publication date | 2019-02-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients | |
| P478 | volume | 14 |
| Q92131404 | Kinking of Bilateral Internal Carotid Arteries as Cause of Cognitive Dysfunction | cites work | P2860 |
Search more.